Clinical significance of novel biomarkers to predict the natural course of hepatitis B infection

• Main Authors: Weikang Wu (Author), Xiaojie Yuan (Author), Weilu Zhang (Author), Haowei Zhou (Author), Xiangyu Kong (Author), Zhen He (Author), Ting Fu (Author), Wenhua Zhang (Author), Wenling Jia (Author), Chunhui Liang (Author), Haitao Tang (Author), Fengmei Wang (Author), Yancheng Ye (Author), Zhongjun Shao (Author), Zhaohua Ji (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background and aimChronic hepatitis B (CHB) can be divided into immune tolerance (IT), immune clearance (IC), hepatitis B e antigen (HBeAg)-negative inactive/quiescent carrier (ENQ), and HBeAg-negative hepatitis (ENH) phases. The conventional biomarkers used to distinguish these phases have limitati...